China, Sept. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The effectiveness of a personalized digital health intervention for improving adherence to adjuvant endocrine therapy in women with breast cancer (P-DAAC)'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132888
Registration Time: 2026/09/20
Type: Interventional study
Primary Sponsor: Xiangya School of Nursing of Central South University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343533
Published by HT Digital Content Services with permission from Health Daily Digest....